02.06.2022 CompuGroup Medical SE & Co. KGaA  DE000A288904

DGAP-Adhoc: CompuGroup Medical SE & Co. KGaA appoints CFO Michael Rauch as Spokesman of the Managing Directors


 

DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel
CompuGroup Medical SE & Co. KGaA appoints CFO Michael Rauch as Spokesman of the Managing Directors

02-Jun-2022 / 21:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE & Co. KGaA announces that the Administrative Board of CompuGroup Managment SE and CEO Dr. Dirk Wössner decided today in mutual agreement to end his contract as of June 30, 2022, including the resignation from his positions as member of the Administrative Board and as Managing Director. Chief Financial Officer (CFO) Michael Rauch is appointed as Spokesman of the Managing Directors as from 1 July 2022 and as member of the Administrative Board. The number of Managing Directors is reduced from 7 to 5. Apart from Michael Rauch the members continue to be Angela Mazza Teufer, Emanuele Mugnani, Dr. Eckart Pech and Hannes Reichl. The current Managing Director Frank Brecher will report to Michael Rauch as Senior Vice President Operational Excellence and will support the already started transformation towards stronger profitable growth by efficiency and process improvements.


02-Jun-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1367753

 
End of Announcement DGAP News Service

1367753  02-Jun-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1367753&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 113,96
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 9,60
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 29,220 Halten 1.570,12
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
22,48 35,86 0,63 25,08
KBV KCV KUV EV/EBITDA
2,55 8,75 1,32 9,79
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 1,00 3,42 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,99% -20,41% -22,90% -39,88%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP